Document is current
Any future updates will be listed below
-
Authors
Luo, Yuling
Li, Minhua
Lin, Shan
Gong, Zheng
Wang, Sumei
Zhou, Ziqing
Li, Shiyue
-
Funding
Funding for this research was provided by:
Guangdong Special Support Plan (Guangdong Special Support Plan)
Guangzhou Municipal Science and Technology Project (No.2023A04J0570)
Guangdong Key Area R&D Program Key Project (2023B111105006)
Major Project of Guangzhou National Laboratory (GZNL2023A03003)
National Natural Science Foundation of China (82500119)
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 5 January 2026
First Online: 24 January 2026
Declarations
:
: (1) Title of the approved project: Fndc5 modification optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome; (2) Name of the institutional approval committee or unit: ICE for Clinical Research and Animal Trials of The First Affiliated Hospital of Guangzhou Medical University; (3) Approval number: 20240610; (4) Date of approval: 17 July 2024.
: Not applicable.
: The authors report no conflicts of interest.
